†rsrapport Nycomed - Takeda Pharmaceuticals International GmbH

ACCOUNTSCONSOLIDATED ACCOUNTS NOTES4. Income tax expenses2000 1998/99(000)DKK(000)DKK7 monthsAccrued income tax for the year - 104,344 7,289Adjustment of deferred tax for the year 90,059 - 9,328Adjustment opening balance (accrued tax) - 7,199 34,926Adjustment opening balance (deferred tax) 3,288 - 35,326Adjustment of deferred tax due to change ofDanish tax rate from 32% to 30% 32,464 0Total 14,268 - 2,439Accrued income tax / income tax receivable:Accrued beginning of year - 23,270 0Accrued income tax in acquired subsidiaries 0 53,851Foreign currency conversion effect 417 - 2,177Paid income taxes during the year - 30,823 - 32,729Adjustment opening balance 7,199 - 34,926Accrued income tax for the year 104,344 - 7,289Accrued 31. December 57,867 - 23,270Deferred tax:Provision beginning of year 595,116 0Adjustment related to deferred tax inacquired subsidiaries in 1999 10,197 0Deferred tax in acquired subsidiaries 0 547,326Foreign currency conversion effect 2,081 3,136Adjustment opening balance - 3,288 35,326Adjustment for the year - 90,059 9,328Adjustment of deferred tax due to changeof Danish tax rate from 32% to 30% - 32,464 0Provision 31. December 481,583 595,116Deferred tax relates to patent and rights, buildings,other fixed assets, inventory and provisions.–49–